Evidence map›Paper›PMID 35039588›Full record

ArticleScientific reports2022

Engineering surgical stitches to prevent bacterial infection.

Daniela Vieira, Samuel N Angel, Yazan Honjol, Maude Masse, Samantha Gruenheid, Edward J Harvey, Geraldine Merle

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniela Vieira *Experimental Surgery, Faculty of Medicine, McGill University, Montreal, H3A 2B2, Canada.
Samuel N Angel *Experimental Surgery, Faculty of Medicine, McGill University, Montreal, H3A 2B2, Canada.
Yazan HonjolExperimental Surgery, Faculty of Medicine, McGill University, Montreal, H3A 2B2, Canada.
Maude MasseExperimental Surgery, Faculty of Medicine, McGill University, Montreal, H3A 2B2, Canada.
Samantha GruenheidDepartment of Microbiology, Faculty of Medicine, McGill University, Montreal, H3A 2B2, Canada.
Edward J HarveyDepartment of Surgery, Faculty of Medicine, McGill University, Montreal, H3A 0C5, Canada.
Geraldine MerleChemical Engineering Department, Ecole Polytechnique de Montréal, P.O. Box 6079 Station, Montreal, QC, H3C 3A7, Canada. geraldine.merle@polymtl.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical site infections (SSIs) account for a massive economic, physiological, and psychological burden on patients and health care providers. Sutures provide a surface to which bacteria can adhere, proliferate, and promote SSIs. Current methods for fighting SSIs involve the use of sutures coated with common antibiotics (triclosan). Unfortunately, these antibiotics have been rendered ineffective due to the increasing rate of antibiotic resistance. A promising new avenue involves the use of metallic nanoparticles (MNPs). MNPs exhibit low cytotoxicity and a strong propensity for killing bacteria while evading the typical antibiotic resistance mechanisms. In this work, we developed a novel MNPs dip-coating method for PDS-II sutures and explored the capabilities of a variety of MNPs in killing bacteria while retaining the cytocompatibility. Our findings indicated that our technique provided a homogeneous coating for PDS-II sutures, maintaining the strength, structural integrity, and degradability. The MNP coatings possess strong in vitro antibacterial properties against P aeruginosa and S. aureus-varying the %of dead bacteria from ~ 40% (for MgO NPs) to ~ 90% (for Fe

Indexed as

Metal NanoparticlesSuturesAnti-Bacterial AgentsAnti-Infective Agents, LocalBacterial InfectionsCoated Materials, BiocompatibleDrug Resistance, BacterialPseudomonas aeruginosaStaphylococcus aureusSurgical Wound InfectionTechnology, PharmaceuticalTriclosanAnti-Bacterial AgentsAnti-Infective Agents, LocalCoated Materials, BiocompatibleTriclosan

Identifiers

PMID35039588
PMCPMC8764053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.